Literature DB >> 10770180

A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.

C J Haven1, F K Wong, E W van Dam, R van der Juijt, C van Asperen, J Jansen, C Rosenberg, M de Wit, J Roijers, J Hoppener, C J Lips, C Larsson, B T Teh, H Morreau.   

Abstract

Familial primary hyperparathyroidism is the main feature of 2 familial endocrine neoplasia syndromes: multiple endocrine neoplasia type 1 (MEN 1) and hyperparathyroidism-jaw tumor syndrome (HPT-JT). The latter is a recently described syndrome that has been associated with ossifying fibroma of the jaw and various types of renal lesions, including benign cysts, Wilms' tumor, and hamartomas. To further illustrate the natural history of this syndrome, we describe a large, previously unreported Dutch kindred in which 13 affected members presented with either parathyroid adenoma or carcinoma; in 5 affected individuals, cystic kidney disease was found. Additionally, pancreatic adenocarcinoma, renal cortical adenoma, papillary renal cell carcinoma, testicular mixed germ cell tumor with major seminoma component, and Hürthle cell thyroid adenoma were also identified. Linkage analysis of the family using MEN1-linked microsatellite markers and mutation analysis excluded the involvement of the MEN1 gene. Using markers from the HPT-JT region in 1q2531, cosegregation with the disease was found, with a maximum logarithm of odds score of 2.41 obtained for 6 markers using the most conservative calculation. Meiotic telomeric recombination between D1S413 and D1S477 was identified in 3 affected individuals, and when combined with previous reports, delineated the HPT-JT region to 14 centimorgan. Combined comparative genomic hybridization and loss of heterozygosity data revealed complex genetic abnormalities in the tumors, suggesting different possible genetic mechanisms for the disease. In conclusion, we report a family with hyperparathyroidism linked to chromosome 1q, and exhibiting several types of renal and endocrine tumors that have not been previously described.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770180     DOI: 10.1210/jcem.85.4.6518

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Immunohistochemical assessment of parafibromin in mouse and human tissues.

Authors:  Andrea Porzionato; Veronica Macchi; Luisa Barzon; Giulia Masi; Maurizio Iacobone; Anna Parenti; Giorgio Palù; Raffaele De Caro
Journal:  J Anat       Date:  2006-12       Impact factor: 2.610

2.  [Prophylactic parathyroidectomy for familial parathyroid carcinoma].

Authors:  O Gimm; K Lorenz; P Nguyen Thanh; U Schneyer; M Bloching; V M Howell; D J Marsh; B T Teh; U Krause; H Dralle
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

Review 3.  Familial adult renal neoplasia.

Authors:  M Takahashi; R Kahnoski; D Gross; D Nicol; B T Teh
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

4.  PLANT HOMOLOGOUS TO PARAFIBROMIN is a component of the PAF1 complex and assists in regulating expression of genes within H3K27ME3-enriched chromatin.

Authors:  Sunchung Park; Sookyung Oh; Julissa Ek-Ramos; Steven van Nocker
Journal:  Plant Physiol       Date:  2010-04-02       Impact factor: 8.340

Review 5.  Benign fibro-osseous lesions of the craniofacial complex. A review.

Authors:  Roy Eversole; Lan Su; Samir ElMofty
Journal:  Head Neck Pathol       Date:  2008-05-13

Review 6.  An Overview of Autosomal Dominant Tumour Syndromes with Prominent Features in the Oral and Maxillofacial Region.

Authors:  Robert A Kennedy; Selvam Thavaraj; Salvador Diaz-Cano
Journal:  Head Neck Pathol       Date:  2017-01-21

7.  High prevalence of simple kidney cysts in patients with primary hyperparathyroidism.

Authors:  S Corbetta; C Eller-Vainicher; L Vicentini; S Carnicelli; F Sardanelli; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2009-05-26       Impact factor: 4.256

Review 8.  Familial parathyroid tumors: diagnosis and management.

Authors:  Peter Stålberg; Tobias Carling
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

9.  HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.

Authors:  V M Howell; C J Haven; K Kahnoski; S K Khoo; D Petillo; J Chen; G J Fleuren; B G Robinson; L W Delbridge; J Philips; A E Nelson; U Krause; K Hammje; H Dralle; C Hoang-Vu; O Gimm; D J Marsh; H Morreau; B T Teh
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

10.  A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome.

Authors:  Virginia Bellido; Ihintza Larrañaga; Maite Guimón; Rafael Martinez-Conde; Asier Eguia; Gustavo Perez de Nanclares; Luis Castaño; Sonia Gaztambide
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.